MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 53 filers reported holding MERSANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $195,000 | -28.8% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $274,000 | -16.0% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $326,000 | -42.6% | 21,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $568,000 | +82.1% | 21,000 | +7.1% | 0.00% | 0.0% |
| Q1 2018 | $312,000 | -32.3% | 19,600 | -34.7% | 0.00% | -50.0% |
| Q4 2017 | $461,000 | 0.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $461,000 | -31.8% | 30,000 | -40.0% | 0.00% | -20.0% |
| Q2 2017 | $676,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |